Andrew Mok
Stock Analyst at Barclays
(3.49)
# 851
Out of 5,138 analysts
252
Total ratings
56.98%
Success rate
2.17%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $386 → $391 | $338.96 | +15.35% | 14 | Jan 5, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $144 → $164 | $193.74 | -15.35% | 11 | Jan 5, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $234 → $245 | $283.95 | -13.72% | 15 | Jan 5, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $385 → $404 | $381.93 | +5.78% | 15 | Jan 5, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $300 → $305 | $277.94 | +9.74% | 10 | Jan 5, 2026 | |
| OSCR Oscar Health | Upgrades: Equal-Weight | $13 → $18 | $17.42 | +3.33% | 4 | Jan 5, 2026 | |
| CNC Centene | Upgrades: Overweight | $44 → $54 | $47.27 | +14.24% | 13 | Jan 5, 2026 | |
| CVS CVS Health | Maintains: Overweight | $87 → $93 | $81.36 | +14.31% | 12 | Dec 10, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $17 → $14 | $11.91 | +17.55% | 19 | Dec 4, 2025 | |
| ASTH Astrana Health | Maintains: Equal-Weight | $36 → $26 | $27.40 | -5.11% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $229 → $240 | $201.32 | +19.21% | 16 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $24 → $18 | $16.00 | +12.50% | 5 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $72.99 | +17.82% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $9.5 → $14 | $11.25 | +24.44% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $23 | $23.86 | -3.60% | 10 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.5 → $1 | $1.02 | -1.96% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $111 → $117 | $109.80 | +6.56% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $22.50 | -20.00% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $141 → $150 | $102.80 | +45.91% | 18 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $149 → $143 | $105.84 | +35.11% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $250 → $263 | $204.19 | +28.80% | 25 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $495 → $525 | $483.80 | +8.52% | 15 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5.5 → $9.5 | $9.76 | -2.66% | 2 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.34 | +4.79% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $10.89 | +10.19% | 1 | Dec 8, 2022 |
UnitedHealth Group
Jan 5, 2026
Maintains: Overweight
Price Target: $386 → $391
Current: $338.96
Upside: +15.35%
Molina Healthcare
Jan 5, 2026
Maintains: Underweight
Price Target: $144 → $164
Current: $193.74
Upside: -15.35%
Humana
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $234 → $245
Current: $283.95
Upside: -13.72%
Elevance Health
Jan 5, 2026
Maintains: Overweight
Price Target: $385 → $404
Current: $381.93
Upside: +5.78%
The Cigna Group
Jan 5, 2026
Maintains: Overweight
Price Target: $300 → $305
Current: $277.94
Upside: +9.74%
Oscar Health
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $17.42
Upside: +3.33%
Centene
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $47.27
Upside: +14.24%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $81.36
Upside: +14.31%
Acadia Healthcare Company
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $11.91
Upside: +17.55%
Astrana Health
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $27.40
Upside: -5.11%
Nov 21, 2025
Maintains: Overweight
Price Target: $229 → $240
Current: $201.32
Upside: +19.21%
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $16.00
Upside: +12.50%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $72.99
Upside: +17.82%
Nov 11, 2025
Upgrades: Overweight
Price Target: $9.5 → $14
Current: $11.25
Upside: +24.44%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $23.86
Upside: -3.60%
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $1.02
Upside: -1.96%
Nov 4, 2025
Maintains: Underweight
Price Target: $111 → $117
Current: $109.80
Upside: +6.56%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $22.50
Upside: -20.00%
Oct 30, 2025
Maintains: Overweight
Price Target: $141 → $150
Current: $102.80
Upside: +45.91%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $149 → $143
Current: $105.84
Upside: +35.11%
Oct 28, 2025
Maintains: Overweight
Price Target: $250 → $263
Current: $204.19
Upside: +28.80%
Oct 27, 2025
Maintains: Buy
Price Target: $495 → $525
Current: $483.80
Upside: +8.52%
Aug 19, 2025
Upgrades: Overweight
Price Target: $5.5 → $9.5
Current: $9.76
Upside: -2.66%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.34
Upside: +4.79%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $10.89
Upside: +10.19%